Immune to Cancer: The CRI Blog
-
Overcoming Immune Dysfunction in Brain Cancer with CRI Lloyd J. Old STAR Peter Fecci
CRI Arash Ferdowsi Lloyd J. Old STAR Peter Fecci is seeking to characterize and develop ways to…
-
Acute Lymphoblastic Leukemia Survivor Kristin Kleinhofer Takes Over CRI’s Instagram
Patient advocate and leukemia survivor Kristin shares a day in her life on Instagram.
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’
During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…
-
How Immunotherapy Is Transforming Bladder Cancer Treatment
Arjun V. Balar, MD, discusses checkpoint immunotherapy, new FDA approvals, promising new therapies, and clinical trials for…
-
AACR20 Day 2 Highlights: COVID-19, Adoptive Cell Therapy, and Checkpoint Immunotherapy Insights
The second day of AACR’s annual meeting heard from experts at cancer centers in COVID-19 hotspots around…
-
COVID-19 and the Immune System: How Cancer Research Can Help Rein in the Novel Coronavirus Pandemic
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.
-
Meet Dr. Yvonne Chen, One of Our New Lloyd J. Old STAR Scientists
We spoke with Dr. Yvonne Chen to learn more about her work in chemical engineering to fight…
-
The Promise of CAR T Cell Therapy in 2019 and Beyond
Dr. Michel Sadelain discusses what’s next in CAR T cell therapy, including the remarkable benefits and the…